Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation

Acta Haematologica

Volumn 126, Issue 1, 2011, Pages 13-20

  De Angelis, Claudia ^a   Mancusi, Antonella ^a   Ruggeri, Loredana ^a   Capanni, Marusca ^a   Urbani, Elena ^a   Velardi, Andrea ^a   Stern, Martin ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute myeloid leukemia; Graft versus leukemia effect; Haploidentical hematopoietic stem cell transplantation; Natural killer cells

Indexed keywords

CD16 ANTIGEN; CD161 ANTIGEN; CD244 ANTIGEN; CD56 ANTIGEN; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYMPHOCYTE ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOIMMUNITY; ARTICLE; CELL EXPANSION; CELL MEDIATED CYTOTOXICITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; GRAFT RECIPIENT; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; T CELL DEPLETION;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD56; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; RECEPTORS, IGG; RECEPTORS, KIR;

EID: 79952611558     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000323661     Document Type: Article

References (31)

1. Caligiuri MA: Human natural killer cells. Blood 2008; 112:461-469.
2. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell sub-sets. Trends Immunol 2001; 22:633-640. (Pubitemid 33043908)
3. Trinchieri G: Biology of natural killer cells. Adv Immunol 1989; 47:187-376. (Pubitemid 20010960)
4. Karre K: Immunology. A perfect mismatch. Science 2002; 295:2029-2031.
5. Ljunggren HG, Karre K: In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237-244. (Pubitemid 20198988)
6. Moretta L, Moretta A: Killer immunoglobu-lin-like receptors. Curr Opin Immunol 2004; 16: 626-633.
7. Parham P: Taking license with natural killer cell maturation and repertoire development. Immunol Rev 2006; 214:155-160. (Pubitemid 44707909)
8. Ruggeri L, Aversa F, Martelli MF, Velardi A: Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol Rev 2006; 214:202-218. (Pubitemid 44707912)
9. Velardi A, Ruggeri L, Moretta A, Moretta L: NK cells: a lesson from mismatched hemato-poietic transplantation. Trends Immunol 2002; 23: 438-444. (Pubitemid 35015187)
10. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 2008; 9: 503-510. (Pubitemid 351560519)
11. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA: Natural killer cell receptors: new biology and insights into the graft-ver-sus-leukemia effect. Blood 2002; 100: 1935-1947. (Pubitemid 35001221)
12. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, Urbani E, Negrin RS, Martelli MF, Velardi A: Role of natural killer cell alloreactivity in HLA-mismatched he-matopoietic stem cell transplantation. Blood 1999; 94: 333-339. (Pubitemid 29300166)
13. Ruggeri L, Capanni M, Urbani E, Perruccio K Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100. (Pubitemid 34229476)
14. Ruggeri L, Mancusi A, Capanni M, Martel-li MF, Velardi A: Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr Opin Immunol 2005; 17:211-217. (Pubitemid 40343110)
15. Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, Stern M, Pende D, Per-ruccio K, Burchielli E, Topini F, Bianchi E, Aversa F, Martelli MF, Velardi A: Donor nat-ural killer cell allorecognition of missing self in haploidentical hematopoietic transplanta-tion for acute myeloid leukemia: challenging its predictive value. Blood 2007; 110:433-440. (Pubitemid 47026866)
16. Velardi A, Ruggeri L, Mancusi A, Burchielli E, Perruccio K, Aversa F, Martel li MF: Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. Semin Immunopathol 2008; 30: 489-503.
17. Alter G, Malenfant JM, Altfeld M: CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22. (Pubitemid 39626587)
18. Eissens DN, Schaap NP, Preijers FW, Dolstra H, van Cranenbroek B, Schattenberg AV, Joosten I, van der Meer A: CD3(+)/CD19(+)-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A. Leu-kemia 2009.
19. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugo-lini S, Vivier E: Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25:331-342. (Pubitemid 44224147)
20. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Ca-ligiuri MA: Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001; 97: 3146-3151.
21. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, O'Shea MA, Kint-er A, Kovacs C, Moretta A, Fauci AS: Char-acterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individu-als. Proc Natl Acad Sci U S A 2005; 102:2886-2891. (Pubitemid 40299886)
22. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, Farschi A, Follmann D, Gregg R, Kovacs C, Marcenaro E, Pende D, Moretta A, Fauci AS: Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006; 203: 2339-2350. (Pubitemid 44498368)
23. Gonzalez VD, Falconer K, Bjorkstrom NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK: Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavi-rin treatment. J Immunol 2009; 183: 6612-6618.
24. Zarife MA, Reis EA, Carmo TM, Lopes GB, Brandao EC, Silva HR, Santana N, Martins-Filho OA, Reis MG: Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56-NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood do-nors with HCV. J Med Virol 2009; 81: 49-59.
25. Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho A, Lage PS, Eloi-Santos SM, Correa-Oliveira R, Martins-Filho OA: Chagasic patients with indetermi-nate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+ CD25 High regulatory T lymphocytes. Scand J Immunol 2005; 62: 297-308. (Pubitemid 41413649)
26. Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KM: KIR acquisi-tion probabilities are independent of self-HLA class I ligands and increase with cellu-lar KIR expression. Blood 2009; 114:95-104.
27. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu K: Hierarchy of the Human Natu-ral Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1. The Journal of Immunology 2007; 179: 5977-5989.
28. Lu X, Kondo Y, Takamatsu H, Ohata K Yamazaki H, Takami A, Akatsuka Y, Nakao S: CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft-versus-leukemia effect. Eur J Hae-matol 2008; 81: 18-25. (Pubitemid 351852752)
29. Dunbar EM, Buzzeo MP, Levine JB, Schold JD, Meier-Kriesche HU, Reddy V: The rela-tionship between circulating natural killer cells after reduced intensity conditioning he-matopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica 2008; 93: 1852-1858.
30. Willemze R, Rodrigues CA, Labopin M, Sanz G Michel G Socie G, Rio B, Sirvent A, Renaud M, Madero L, Mohty M, Ferra C, Garnier F, Loiseau P, Garcia J, Lecchi L, Ko-gler G, Beguin Y, Navarrete C, Devos T, Io-nescu I, Boudjedir K, Herr AL, Gluckman E, Rocha V: KIR-ligand incompatibility in the graft-versus-host direction improves out-comes after umbilical cord blood transplan-tation for acute leukemia. Leukemia 2009; 23: 492-500.
31. Vago L, Forno B, Sormani MP, Crocchiolo R, Zino E, Di Terlizzi S, Lupo Stanghellini MT, Mazzi B, Perna SK, Bondanza A, Middleton D Palini A, Bernardi M, Bacchetta R Pec-catori J, Rossini S, Roncarolo MG, Bordi-gnon C, Bonini C, Ciceri F, Fleischhauer K: Temporal, quantitative, and functional char-acteristics of single-KIR-positive alloreac-tive natural killer cell recovery account for impaired graft-versus-leukemia activity af-ter haploidentical hematopoietic stem cell transplantation. Blood 2008; 112:3488-3499.